PHARMACEUTICAL AGENTS

THE INVENTION PROVIDES A PHARMACEUTICAL COMPOSITION COMPRISING A PARTICULAR PHYSICAL FORM OF N-[4-[5-(CYCLOPENTYLOXY-CARBONYL)AMINO-1- METHYLINDOL-3-YL-METHYL]-3-METHOXYBENZOYL]-2-METHYL-BENZENESULPHONAMIDE AND POLYVINYLPYRROLIDONE. IT ALSO PROVIDES METHODS FOR PREPARING THIS PHYSICAL FORM, AND ANOT...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: RANDY JOHN BRADWAY, IEUAN JOHN EDWARDS, ROBERT JOSEPH TIMKO, JAMES JOSEPH HOLOHAN, ARLENE CLEMENTS
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:THE INVENTION PROVIDES A PHARMACEUTICAL COMPOSITION COMPRISING A PARTICULAR PHYSICAL FORM OF N-[4-[5-(CYCLOPENTYLOXY-CARBONYL)AMINO-1- METHYLINDOL-3-YL-METHYL]-3-METHOXYBENZOYL]-2-METHYL-BENZENESULPHONAMIDE AND POLYVINYLPYRROLIDONE. IT ALSO PROVIDES METHODS FOR PREPARING THIS PHYSICAL FORM, AND ANOTHER PHYSICAL FORM OF N-[4-[5-(CYCLOPENTYLOXYCARBONYL)AMINO-1-METHYLINDOL-3-YL-METHYL]-3-METHOXYBENZOYL]-2-METHYLBENZENESULPHONAMIDE USEFUL IN THE PREPARATION OF THE FIRST MENTIONED PHYSICAL FORM. THE COMPOSITIONS ARE USEFUL IN THE TREATMENT OF DISEASES IN WHICH LEUKOTRIENES ARE IMPLICATED, FOR EXAMPLE ASTHMA.